Back to Search
JEFFREY WEITZEL, MD
MD
Hematology & Oncology Physician
NPI: 1952368516IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical Genetics (M.D.) Physician
Medical Genetics — Clinical Genetics (M.D.)
Code: 207SG0201X
G83409(CA)04-48901(KS)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
04-48901(KS)G83409(CA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1988
Research & Publications (20)
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
PMID 19584272·Cancer Res·2009
4-observational
Survey of unaffected BRCA and mismatch repair (MMR) mutation positive individuals.
PMID 19466581·Fam Cancer·2009
4-observational
An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature.
PMID 18500673·Breast Cancer Res Treat·2009
6-review
The Active Living Research program: six years of grantmaking.
PMID 19147053·Am J Prev Med·2009
8-other
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
PMID 19204208·J Clin Oncol·2009
8-other
Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics.
PMID 19333752·Breast Cancer Res Treat·2009
8-other
Development and validation of the Retrospective Alcohol Context Scale.
PMID 19322732·Am J Drug Alcohol Abuse·2009
4-observational
High expression of thyroid hormone receptors and mitochondrial glycerol-3-phosphate dehydrogenase in the liver is linked to enhanced fatty acid oxidation in Lou/C, a rat strain resistant to obesity.
PMID 19049970·J Biol Chem·2009
7-preclinical
Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer.
PMID 18646245·Psychooncology·2008
8-other
Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.
PMID 18836779·Ann Surg Oncol·2008
4-observational
Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk.
PMID 18953408·PLoS One·2008
8-other
Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians.
PMID 18978681·Genet Med·2008
8-other
T3-mediated expression of PGC-1alpha via a far upstream located thyroid hormone response element.
PMID 18336995·Mol Cell Endocrinol·2008
7-preclinical
Rapid progression of prostate cancer in men with a BRCA2 mutation.
PMID 18577985·Br J Cancer·2008
8-other
To bind or not to bind - how to down-regulate target genes by liganded thyroid hormone receptor?
PMID 19014660·Thyroid Res·2008
8-other
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
PMID 18355772·Am J Hum Genet·2008
4-observational
Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas.
PMID 18508193·Mol Cell Endocrinol·2008
6-review
The role of thyroid hormone receptor DNA binding in negative thyroid hormone-mediated gene transcription.
PMID 18562675·J Mol Endocrinol·2008
4-observational
BRCA mutations and the risk of angiosarcoma after breast cancer treatment.
PMID 19073510·Clin Breast Cancer·2008
5-case
Self-reported consequences of intoxication among college students: implications for harm reduction approaches to high-risk drinking.
PMID 19438069·J Drug Educ·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4000 CAMBRIDGE ST
KANSAS CITY, KS 66160 - Phone
- (913) 588-6656
Quick Facts
- NPI
- 1952368516
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile